183 related articles for article (PubMed ID: 24636026)
21. Cryoglobulinemic neuropathy related to hepatitis C virus infection. Clinical, laboratory and neurophysiological study.
Caniatti LM; Tugnoli V; Eleopra R; Tralli G; Bassi R; De Grandis D
J Peripher Nerv Syst; 1996; 1(2):131-8. PubMed ID: 10975721
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia.
Frangeul L; Musset L; Cresta P; Cacoub P; Huraux JM; Lunel F
J Hepatol; 1996 Oct; 25(4):427-32. PubMed ID: 8912140
[TBL] [Abstract][Full Text] [Related]
23. Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha.
Zuckerman E; Keren D; Slobodin G; Rosner I; Rozenbaum M; Toubi E; Sabo E; Tsykounov I; Naschitz JE; Yeshurun D
J Rheumatol; 2000 Sep; 27(9):2172-8. PubMed ID: 10990230
[TBL] [Abstract][Full Text] [Related]
24. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
Landau DA; Saadoun D; Halfon P; Martinot-Peignoux M; Marcellin P; Fois E; Cacoub P
Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235
[TBL] [Abstract][Full Text] [Related]
25. Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection.
Benstead TJ; Chalk CH; Parks NE
Cochrane Database Syst Rev; 2014 Dec; (12):CD010404. PubMed ID: 25525951
[TBL] [Abstract][Full Text] [Related]
26. Antiviral therapy of symptomatic HCV-mixed cryoglobulinemia after liver transplant: case report and literature review.
Francesca Donato M; Banfi G; Cresseri D; Battista Fogazzi G; Martin P; Messa P; Fabrizi F
Int J Artif Organs; 2013 May; 36(5):367-72. PubMed ID: 23446762
[TBL] [Abstract][Full Text] [Related]
27. Interferon-alpha treatment of hepatitis C virus-associated mixed cryoglobulinemia.
Polzien F; Schott P; Mihm S; Ramadori G; Hartmann H
J Hepatol; 1997 Jul; 27(1):63-71. PubMed ID: 9252075
[TBL] [Abstract][Full Text] [Related]
28. Clinical relevance of total HCV core antigen testing for hepatitis C monitoring and for predicting patients' response to therapy.
Maynard M; Pradat P; Berthillon P; Picchio G; Voirin N; Martinot M; Marcellin P; Trepo C
J Viral Hepat; 2003 Jul; 10(4):318-23. PubMed ID: 12823600
[TBL] [Abstract][Full Text] [Related]
29. Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma.
Feldmann G; Nischalke HD; Nattermann J; Banas B; Berg T; Teschendorf C; Schmiegel W; Dührsen U; Halangk J; Iwan A; Sauerbruch T; Caselmann WH; Spengler U
Clin Cancer Res; 2006 Aug; 12(15):4491-8. PubMed ID: 16899594
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C virus but not GB virus C/hepatitis G virus has a role in type II cryoglobulinemia.
Liu F; Knight GB; Agnello V
Arthritis Rheum; 1999 Sep; 42(9):1898-901. PubMed ID: 10513805
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of hepatitis C virus-associated mixed cryoglobulinemia after liver transplantation.
Abrahamian GA; Cosimi AB; Farrell ML; Schoenfeld DA; Chung RT; Pascual M
Liver Transpl; 2000 Mar; 6(2):185-90. PubMed ID: 10719018
[TBL] [Abstract][Full Text] [Related]
32. Kinetics of hepatitis C (HCV) viraemia and quasispecies during treatment of HCV associated cryoglobulinaemia with pulse cyclophosphamide.
Thiel J; Peters T; Mas Marques A; Rösler B; Peter HH; Weiner SM
Ann Rheum Dis; 2002 Sep; 61(9):838-41. PubMed ID: 12176813
[TBL] [Abstract][Full Text] [Related]
33. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
34. Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study.
Mazzaro C; Zorat F; Caizzi M; Donada C; Di Gennaro G; Maso LD; Carniello G; Virgolini L; Tirelli U; Pozzato G
J Hepatol; 2005 May; 42(5):632-8. PubMed ID: 15826710
[TBL] [Abstract][Full Text] [Related]
35. Mixed cryoglobulinemia and hepatitis C virus.
Cacoub P; Fabiani FL; Musset L; Perrin M; Frangeul L; Leger JM; Huraux JM; Piette JC; Godeau P
Am J Med; 1994 Feb; 96(2):124-32. PubMed ID: 7509124
[TBL] [Abstract][Full Text] [Related]
36. Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study.
Dammacco F; Tucci FA; Lauletta G; Gatti P; De Re V; Conteduca V; Sansonno S; Russi S; Mariggiò MA; Chironna M; Sansonno D
Blood; 2010 Jul; 116(3):343-53. PubMed ID: 20308602
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role.
Zignego AL; Ferri C; Giannini C; La Civita L; Careccia G; Longombardo G; Bellesi G; Caracciolo F; Thiers V; Gentilini P
Arch Virol; 1997; 142(3):545-55. PubMed ID: 9349300
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C virus-associated type II mixed cryoglobulinemia vasculitis complicated with membranous proliferative glomerulonephritis.
Lo KY; Chen CY; Lee CS
Ren Fail; 2009; 31(2):149-52. PubMed ID: 19212913
[TBL] [Abstract][Full Text] [Related]
39. Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia.
Gragnani L; Visentini M; Fognani E; Urraro T; De Santis A; Petraccia L; Perez M; Ceccotti G; Colantuono S; Mitrevski M; Stasi C; Del Padre M; Monti M; Gianni E; Pulsoni A; Fiorilli M; Casato M; Zignego AL
Hepatology; 2016 Nov; 64(5):1473-1482. PubMed ID: 27483451
[TBL] [Abstract][Full Text] [Related]
40. Pattern of HCV antibodies with special reference to NS5A reactivity in HCV-infected patients: relation to viral genotype, cryoglobulinemia and response to interferon.
Frangeul L; Cresta P; Perrin M; Duverlie G; Khorsi H; Musset L; Opolon P; Huraux JM; Lunel F
J Hepatol; 1998 Apr; 28(4):538-43. PubMed ID: 9566820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
